UnitedHealth Group (NYSE:UNH) Shares Sold Off Rep. Richard McCormick

Representative Richard McCormick (Republican-Georgia) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on August 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 30th. The trade occurred in the Representative’s “GROWTH PARTNERS ROTH IRA” account.

Representative Richard McCormick also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Medtronic (NYSE:MDT) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of NextEra Energy (NYSE:NEE) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of L3Harris Technologies (NYSE:LHX) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Intercontinental Exchange (NYSE:ICE) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Illinois Tool Works (NYSE:ITW) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 7/30/2026.

UnitedHealth Group Trading Up 0.4%

Shares of UnitedHealth Group stock traded up $1.75 on Tuesday, hitting $397.37. 706,030 shares of the company’s stock traded hands, compared to its average volume of 7,908,625. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The stock has a market capitalization of $356.67 billion, a PE ratio of 25.59, a price-to-earnings-growth ratio of 1.40 and a beta of 0.62. The firm’s 50-day moving average price is $415.52 and its two-hundred day moving average price is $353.65.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s payout ratio is currently 59.72%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $287.00 to $453.00 in a report on Thursday, July 16th. Oppenheimer increased their target price on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Bank of America reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 20th. Royal Bank Of Canada raised their target price on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a report on Friday, July 17th. Finally, Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $455.92.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the company’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer owned 16,497 shares in the company, valued at approximately $6,763,770. This represents a 2.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is currently owned by company insiders.

Institutional Trading of UnitedHealth Group

Institutional investors have recently added to or reduced their stakes in the stock. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group in the fourth quarter worth $25,000. Anfield Capital Management LLC boosted its stake in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $27,000. Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Lifetime Wealth Management P.C. purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $29,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth authorized a dividend, providing ongoing shareholder income and signaling confidence in its financial position. However, the announcement came amid a governance lawsuit, limiting its positive effect. UnitedHealth Group Authorizes Dividend Amid Governance Lawsuit
• Positive Sentiment: Wall Street’s average brokerage recommendation remains favorable, suggesting analysts see potential upside following UnitedHealth’s better-than-expected latest quarterly earnings and full-year 2026 earnings guidance. The bullish view is tempered by the possibility that analyst ratings are overly optimistic. Wall Street Bulls Look Optimistic About UnitedHealth
• Neutral Sentiment: The reported expected guilty plea by Luigi Mangione in the federal case involving former UnitedHealthcare CEO Brian Thompson could reduce legal uncertainty surrounding the high-profile killing, but it has limited direct implications for UnitedHealth’s operating results. Luigi Mangione Reportedly Set to Plead Guilty
• Negative Sentiment: A derivative lawsuit alleges UnitedHealth executives knew that patients were winning roughly 90% of appeals against AI-assisted coverage denials. The claims raise potential litigation, regulatory, reputational, and medical-cost risks. UNH Patients Win 90% of AI Denial Appeals
• Negative Sentiment: Another investor lawsuit alleges that UnitedHealth concealed governance and cybersecurity deficiencies, discontinued an internal Medicare billing audit, and failed to address weaknesses linked to the Change Healthcare cyberattack. If substantiated, the allegations could increase legal costs and regulatory scrutiny. Investor Suit Says UnitedHealth Ignored Governance and Cybersecurity Gaps
• Negative Sentiment: Analysts argue that much of UnitedHealth’s expected margin recovery may already be reflected in the valuation, making future revenue and earnings growth the next major test for the stock. UnitedHealth Margin Recovery Is Priced In

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia’s 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 7th Congressional District. He declared candidacy for the 2026 election.

Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick’s career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.